Medical Journals: Allergy and Asthma Proceedings is the Official Journal of Regional, State, and, Local Allergy, Asthma and Immunology Societies (RSLAAIS) and the American Association of Certified Allergists (AACA).

Allergy and Asthma Proceedings utilizes an online system of manuscript submission, editing and review. This system allows authors to submit their work online and check on the status of the review process. To access the electronic system, visit http://aap.msubmit.net. This technology requires all manuscript files be uploaded separately as follows:

Copyright release forms and conflict of interest forms must be sent via mail or fax. Forms may be downloaded: Publishing Forms (pdf file). If figures are scanned, please also forward the original (glossy) figures to the editorial offices. These will produce a higher quality output in the printing process. Electronic submission is a four step process that is described step-by-step on the http://aap.msubmit.net site. Allergy and Asthma Proceedings will no longer accommodate the submission of paper manuscripts unless prior permission is granted via the editorial office. Please contact the editorial offices with any questions regarding the submission process.

MANUSCRIPT PREPARATION GUIDELINES:
Please note: Failure to follow these format instructions may result in the manuscript being returned to the author(s) for revision prior to review

SELECTING A MANUSCRIPT TYPE: when uploading your completed manuscript, you will be required to designate a manuscript type.

Please note: Failure to follow these format instructions may result in the manuscript being returned to the author(s) for revision prior to review SELECTING A MANUSCRIPT TYPE: when uploading your completed manuscript, you will be required to designate a manuscript type.

Review: Manuscript that provides a review of previously published literature. Components indicated by a checkmark below should appear in the order they are presented here (ie. title page, abstract, manuscript text, acknowledgment, references, figure legends, tables, figures)
Original manuscript: Provides the results of original laboratory and/or clinical research. Components indicated by a checkmark below should appear in the order they are presented here (ie. title page, abstract, manuscript text, acknowledgment, references, figure legends, tables, figures)
Letters to the Editor: Letters to the editor will be reviewed by the Editor(s) and peer-reviewed. Letters to the editor are limited to 500 words and 5 references. As letters to the editor are indexed and cited like original articles, key words are also required.
Case Reports: With the exception of the POPS Case Reports (exclusively for FITs), Allergy and Asthma Proceedings does not encourage the submission of case reports. Only those submitted that are truly unique and have an exceptional teaching value will be considered for publication.
Solicited Meeting paper: If the solicited manuscript was written based upon a presentation at a scientific meeting of either the Eastern Allergy Conference or the Southwest Allergy Forum, please select this manuscript type. Components indicated by a checkmark below should appear in the order they are presented here (i.e. title page, abstract, manuscript text, acknowledgment, references, figure legends, tables, figures). The corresponding scientific meeting should be included on the title page in the format of the name of the meeting, city, state (or country), date of meeting. i.e. "Presented at the Eastern Allergy Conference, Naples, Florida, May 15, 2009"
Solicited Symposium: If the manuscript was solicited to precede, accompany or follow a pre, mid or post-conference symposium presentation at a scientific meeting of either the Eastern Allergy Conference (EAC) or the Combined EAC/Southwest Allergy Forum, please select this manuscript type. The corresponding scientific meeting should be included on the title page in the format of the name of the meeting, city, state (or country), date of meeting. i.e. "Presented at the pre-conference symposium of the Eastern Allergy Conference, Naples, Florida, May 15, 2009" Symposium manuscripts are supported by unrestricted educational grants which must be disclosed on the title page of the manuscript. i.e. "Supported by an unrestricted educational grant from Z Pharmaceuticals" Components indicated by a checkmark below should appear in the order they are presented here (ie. title page, abstract, manuscript text, acknowledgment, references, figure legends, tables, figures)
POPS Case Reports: Submissions are limited to A/I FITs only. APPENDIX A FOR ADDITIONAL INSTRUCTIONS
Clinical Pearls and Pitfalls: The objective of the Clinical Pearls section of the Allergy and Asthma Proceedings is to provide the reader with a brief and concise review of a given topic. Emphasis should focus on salient clinical features and topics of interest for both the practicing physician as well as the fellow-in-training. Manuscripts should consist of one question followed by a brief and concise review following a strictly structured format. SEE ATTACHED APPENDIX B FOR FORMAT GUIDELINES AND ADDITIONAL INSTRUCTIONS

Title page:
Include full relevant and concise (no more than 15 words) title in sentence format (only capitalize proper nouns). Never include abbreviations in the title.
First name, middle initial, last name of each author with highest academic degrees included (do not include fellowships)
Name of Departments and Institutions to which work should be attributed; (see Conflict of Interest below)
Disclaimers (if any); and Acknowledgment of Financial Support/Funding.(see Conflict of Interest)
In studies involving human subjects, a statement describing approval by the Institutional Review Board is required.
Key Words (10 key words are mandatory) Selecting appropriate key words is essential to your research being discovered by others.
Include date of presentation at scientific meeting (if any)
Include corresponding author's telephone number, FAX number and e-mail address

Abstract: All manuscript types with the exception of the Letters to the Editors must include a structured abstract, no longer than 250 words, to precede article. Only include acronyms or abbreviations if the phrase appears more than three times in the abstract. Divided abstract into the following sections:
Background - Describe the problem that prompted the study
Objective - Describe the purpose of the study
Methods - Describe how the study was conducted
Results - Describe the most important findings
Conclusion - Describe the most important conclusion drawn from the study

Text: unspecified length for all manuscript types excluding POPS Case Reports and Clinical Pearls. [See Appendix A for POPS Case Report text format and Appendix B for Clinical Pearls text format.] Manuscript should be typed double-spaced in a standard font such as Times New Roman, Arial, Courier, or Helvetica, in size 12. Manuscript text pages should be numbered. Text should be written in clear and concise English. Authors whose primary language is not English should obtain assistance with writing to avoid grammatical problems. Several independent services for STM authors are available online and include:

Please note: These few sites are only listed as a convenience and are not an endorsement of their products. They are in no way affiliated with the journal and use of their services will not guarantee acceptance of a manuscript.

Acknowledgment: General acknowledgments for consultations, statistical analysis and such should be listed at the end of the text before the References. Include full names of individuals. Any and all acknowledgments of funding must be included on the title page.

References: References in the text should be superscript numbers in order of appearance. Manuscripts in preparation, personal communications, websites, or other unpublished information should not be cited in the reference list but may be mentioned in the text in parentheses. References with more than three authors should be presented as the first three authors followed by et al. Please follow format below, e.g.:

Tables: Tables may be placed within the manuscript or uploaded as separate files (in .doc or .wpd format). If table is included in manuscript file, place after the References section, one table per page. Any abbreviations included in the table should be defined at the bottom of the table. If the table is being republished with permission, proof of permission must be faxed to the editorial office.

Figure legends: Figure legends should be typewritten, double-spaced and listed (numbered) on a separate page after the tables. They should not appear on the figures. Include figure titles at the beginning of the legend.

Figures, and illustrations: Illustrations included in manuscripts must be submitted in electronic format along with the rest of the manuscript. Each figure should be submitted as a separate electronic file - not imbedded in the manuscript text file. See Cadmus guidelines for submitting digital art at http://cpc.cadmus.com/da/guidelines.asp. Figure file preference is .tif, .jpeg, .eps. Proof of permission must be faxed to the editorial office for any figures being republished with permission. Proof of informed consent (signed releases) must be faxed to the editorial office for any and all photographs of identifiable persons.
[See Appendix A for additional information on Figures for POPS Case Report submissions.]
A note about color figures: If your manuscript is accepted for publication and it includes color figures, you will have an option of printing your figures in color or black and white. Due to the high cost of color, please be aware that if you choose to print in color, the cost to you will be $800. There is no cost to print the figures in black and white. Figures submitted in color but printed in black and white will appear at no cost, in color on the online version of the journal.

Copyright release form: MANUSCRIPTS WILL NOT BE REVIEWED UNLESS ACCOMPANIED BY A COPYRIGHT RELEASE FORM SIGNED BY EACH AND EVERY AUTHOR which states "The undersigned author(s) transfer all copyright ownership, including electronic, of the manuscript (title of article) to OceanSide Publications, Inc in the event the work is published. The undersigned warrant(s) that the article is original, does not infringe upon any copyright or other proprietary right of any third party, is not under consideration by another journal, and has not been previously published. The author(s) confirm that they have reviewed and approved the final version of the manuscript." Items are accepted for publication on the understanding that they are contributed solely to Allergy and Asthma Proceedings and have not been or will not be published elsewhere in any format except in abstract form. Blank Copyright Release forms may be downloaded: Publishing Forms (pdf file).

Conflict of Interest form: Allergy and Asthma Proceedings requires all authors listed on the title page of the manuscript to make the following disclosures: On the title page of the manuscript, authors must acknowledge:
a. all funding sources that supported their work and
b. all institutional or corporate affiliations of each author
Also, All authors must submit a separate form (one for each author) stating specifically whether any of the following commercial associations that might pose a conflict of interest exists: consultant arrangements, stock or other equity ownership, patent licensing arrangements, or payments for conducting or publicizing the study. Contact Allergy and Asthma Proceedings for blank Conflict of Interest forms or download them Publishing Forms (pdf file). Disclosures will be held in strict confidence during the review process and will not influence any editorial decisions. However, if the paper is accepted for publication, the Editor will determine how any conflict of interest should be disclosed.

Patient-Oriented Problem Solving (POPS) Case Report
(limited to Allergy-Immunology Fellows-in-Training)

The POPS series case reports will be evaluated on a first come, first serve basis. Case reports should be submitted online at http://aap.msubmit.net. Submissions are limited to A/I FITs only. Please see the following author instructions for these manuscripts:

AAP only accepts abstracts, which are submitted in associated with RSL Allergy Society CME meetings. As a part of this process.

Submission for content review (only): $50. This fee applies to all submitted abstracts, regardless of whether the author is requesting publication.

Submission for Publication: $300 for supported work; $0 for unsupported work (RSL Allergy Society members). Authors have the options for their abstracts to be published in an upcoming issue of the journal, Allergy & Asthma Proceedings. The fee for the publication of supported abstracts is faxed (401) 331-0223, or emailed (susancolucci@oceansidepubl.com) to the Editorial office at the time of submission. Of note, because of possible copyright infringements, abstracts which have been submitted for publication elsewhere will not be published inAllergy & Asthma Proceedings.